FLGT logo

FLGT
Fulgent Genetics Inc

5,702
Mkt Cap
$420.33M
Volume
1.44M
52W High
$31.04
52W Low
$13.46
PE Ratio
-7.19
FLGT Fundamentals
Price
$14.13
Prev Close
$15.19
Open
$14.04
50D MA
$16.26
Beta
0.76
Avg. Volume
440,013.34
EPS (Annual)
-$1.97
P/B
0.39
Rev/Employee
$240,082.59
$475.20
Loading...
Loading...
Poll

Earnings Recap

Fulgent Genetics reiterated full year 2026 revenue guidance of approximately $350.0 million. The company updated its Non-GAAP loss to approximately $46.0 million, or $(1.59) per share, and expects $636.0 million in cash and investments.

Bullish

Fulgent Genetics executed a $40.1 million stock repurchase in Q1 2026 and advanced its therapeutic development pipeline. The company maintains a strong cash position and expects gross margins to improve in the second half.

Bearish

Fulgent Genetics experienced declining Q1 2026 revenue to $71.1 million and increased GAAP losses to $24.8 million, with gross margins compressing to 30.2%. The company also faces customer concentration and tax refund timing risks.

Latest FLGT News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.